Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (10)

2022

  1. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study

    Neurourology and Urodynamics, Vol. 41, Núm. 8, pp. 1824-1833

2020

  1. Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study

    Journal of Medical Imaging and Radiation Oncology, Vol. 64, Núm. 6, pp. 859-865

2018

  1. Cognitive function in patients on androgen suppression: A prospective, multicentric study

    Actas Urologicas Espanolas, Vol. 42, Núm. 2, pp. 114-120

2017

  1. Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study

    International Journal of Radiation Oncology Biology Physics, Vol. 98, Núm. 3, pp. 590-594

  2. Resultados de la radioterapia de ciclo corto seguida de cirugía radical en el cáncer de recto: estudio unicéntrico y observacional a largo plazo

    Cirugia Espanola, Vol. 95, Núm. 5, pp. 268-275

2015

  1. Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 1, pp. 1-11

2013

  1. Current treatment of rectal cancer adapted to the individual patient

    Reports of Practical Oncology and Radiotherapy, Vol. 18, Núm. 6, pp. 353-362

2011

  1. Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: Better pain relief, sleep and physical health

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 656-663

2010

  1. Functional characterization of highly adherent CD34+ keratinocytes isolated from human skin

    Experimental Dermatology

2007

  1. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial

    Lung Cancer, Vol. 58, Núm. 2, pp. 238-245